Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...
Smith, MD, of Glaucoma Associates of Texas, in Dallas, sat down with the Eye Care Network to reflect on how glaucoma care ...
In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...
SAN FRANCISCO--(BUSINESS WIRE)--Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, has launched the third phase of its collaborative research ...
A leading Army hospital in Delhi conducted India's inaugural 3D flex aqueous angiography with iStent, combining advanced ...
Bausch + Lomb has joined forces with the nonprofit Glaucoma Research Foundation (GRF) for the U.S. launch of new eye health campaign “Screen, Protect, Cure.” This campaign is set up to send out ...
Glaucoma, the silent thief of sight, damages the optic nerve without early symptoms, leading to irreversible vision loss.
As part of the fundraising challenge with GRF, Bausch + Lomb will match every dollar raised during January, up to $20,000. All proceeds will support critical research for glaucoma, a leading cause of ...
JOE Lovett, a former glaucoma sufferer who says he cured this dangerous eye disease with coconut oil, says it can help other challenged persons as well. Joe Lovett should know what he is saying. For ...
Macular degeneration and glaucoma can both lead to vision loss. However, macular degeneration tends to affect central vision while glaucoma affects side vision. The causes and treatment are also ...
A person with glaucoma may be able to wear contact lenses. However, this can depend on the severity of their condition, and the type of treatment they receive. Glaucoma is a condition in which ...
This column was first published in April 2022 to signpost the 2022 World Glaucoma Week. It is republished today at the request of many caregivers, challenged persons and readers of this column who ...